Medical Properties Trust, Inc. (MPW) investors to reap big returns again

The top two institutional holders are Vanguard Group, Inc. (The) with over 78.26 Million shares worth more than $1.35 Billion. As of March 30, 2020, …

Medical Properties Trust, Inc. (NYSE:MPW) has a beta value of 0.66 and has seen 1,632,920 shares traded in the recent trading session. The company, currently valued at $10.65 Billion, closed the recent trade at $20.03 per share which meant it gained $0.35 on the day or 1.78% during that session. The MPW stock price is -21.27% off its 52-week high price of $24.29 and 38.34% above the 52-week low of $12.35. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.72 Million shares traded. The 3-month trading volume is 3.74 Million shares.

Sporting 1.78% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jul 29 when the MPW stock price touched $20.22- or saw a rise of 1.39%. Year-to-date, Medical Properties Trust, Inc. shares have moved -5.54%, while the 5-day performance has seen it change 3.53%. Over the past 30 days, the shares of Medical Properties Trust, Inc. (NYSE:MPW) have changed 8.13%. Short interest in the company has seen 15.41 Million shares shorted with days to cover at 4.12.

Medical Properties Trust, Inc. (MPW) estimates and forecasts

Figures show that Medical Properties Trust, Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -12.53% over the past 6 months, with this year growth rate of 18.46%, compared to -4% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 30% and 35% for the next quarter. Revenue growth from the last financial year stood is estimated to be +46%.

6 analysts offering their estimates for the company have set an average revenue estimate of $312.07 Million for the current quarter. 6 have an estimated revenue figure of $320.48 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $192.55 Million and $224.76 Million respectively for this quarter and the next, and analysts expect sales will grow by 62.1% for the current quarter and 42.6% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +24.5% over the past 5 years. Earnings growth for 2020 is a modest -68.6%.

MPW Dividends

Medical Properties Trust, Inc. is expected to release its next earnings report between July 30 and July 30 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.08 at a share yield of 5.49%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 6.49%.

Medical Properties Trust, Inc. (NYSE:MPW)’s Major holders

Insiders own 1.23% of the company shares, while shares held by institutions stand at 84.31% with a share float percentage of 85.37%. Investors are also buoyed by the number of investors in a company, with Medical Properties Trust, Inc. having a total of 694 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 78.26 Million shares worth more than $1.35 Billion. As of March 30, 2020, Vanguard Group, Inc. (The) held 14.81% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 61.91 Million shares as of March 30, 2020. The firm’s total holdings are worth over $1.07 Billion and represent 11.72% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Specialized-Real Estate Index Fund and Vanguard Total Stock Market Index Fund. As of April 29, 2020, the former fund manager holds about 4.48% shares in the company for having 23652954 shares of worth $405.41 Million while later fund manager owns 15.15 Million shares of worth $261.98 Million as of March 30, 2020, which makes it owner of about 2.87% of company’s outstanding stock.

Related Posts:

  • No Related Posts

Stifel Nicolaus Lowers Kirby (NYSE:KEX) Price Target to $48.00

AQR Capital Management LLC now owns 9,018 shares of the shipping company’s stock valued at $807,000 after acquiring an additional 1,835 shares …

Kirby logoKirby (NYSE:KEX) had its price objective reduced by stock analysts at Stifel Nicolaus from $50.00 to $48.00 in a report issued on Wednesday, BenzingaRatingsTable reports. The firm presently has a “hold” rating on the shipping company’s stock. Stifel Nicolaus’ price target would indicate a potential upside of 6.76% from the stock’s previous close.

KEX has been the subject of several other research reports. TheStreet cut Kirby from a “c” rating to a “d+” rating in a report on Tuesday, May 5th. Benchmark began coverage on Kirby in a report on Thursday, April 16th. They issued a “buy” rating and a $65.00 price target for the company. Five research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Kirby has a consensus rating of “Hold” and a consensus target price of $74.86.

Shares of KEX traded down $1.46 during trading hours on Wednesday, hitting $44.96. 5,002 shares of the company were exchanged, compared to its average volume of 506,851. The company has a market cap of $2.72 billion, a PE ratio of -18.01, a PEG ratio of 2.05 and a beta of 1.42. The firm’s 50 day moving average is $51.42 and its 200-day moving average is $57.45. Kirby has a 52 week low of $32.76 and a 52 week high of $92.30. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.07 and a current ratio of 2.76.

Kirby (NYSE:KEX) last released its quarterly earnings results on Tuesday, May 5th. The shipping company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.15. Kirby had a positive return on equity of 5.04% and a negative net margin of 5.49%. The company had revenue of $643.90 million during the quarter, compared to the consensus estimate of $627.88 million. During the same quarter in the prior year, the company posted $0.74 EPS. The firm’s revenue was down 13.5% on a year-over-year basis. As a group, equities analysts forecast that Kirby will post 2.18 earnings per share for the current fiscal year.

(Ad)

Something remarkable happened when I recently visited America’s richest ZIP code. It’s far from Manhattan, Palm Beach, and Beverly Hills. But this place holds a secret that can make you enormous gains (I believe 1,000% or more) in the years to come.

In related news, VP Scott P. Miller sold 607 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $51.71, for a total transaction of $31,387.97. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Kim B. Clarke purchased 1,000 shares of Kirby stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average price of $52.07 per share, for a total transaction of $52,070.00. Following the transaction, the vice president now owns 3,656 shares in the company, valued at $190,367.92. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James & Associates bought a new stake in Kirby during the 4th quarter worth about $321,000. Advisor Group Inc. increased its stake in shares of Kirby by 49.6% in the 4th quarter. Advisor Group Inc. now owns 1,529 shares of the shipping company’s stock valued at $135,000 after acquiring an additional 507 shares during the last quarter. UBS Group AG increased its stake in shares of Kirby by 103.6% in the 4th quarter. UBS Group AG now owns 14,859 shares of the shipping company’s stock valued at $1,331,000 after acquiring an additional 7,560 shares during the last quarter. First Republic Investment Management Inc. bought a new stake in shares of Kirby in the 4th quarter valued at about $204,000. Finally, AQR Capital Management LLC increased its stake in shares of Kirby by 25.5% in the 4th quarter. AQR Capital Management LLC now owns 9,018 shares of the shipping company’s stock valued at $807,000 after acquiring an additional 1,835 shares during the last quarter. Institutional investors and hedge funds own 91.95% of the company’s stock.

Kirby Company Profile

Kirby Corporation operates domestic tank barges in the United States. Its Marine Transportation segment provides marine transportation services and towing vessels transporting bulk liquid products, as well as operates tank barges throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along three United States coasts, and in Alaska and Hawaii.

Read More: Conference Calls

Analyst Recommendations for Kirby (NYSE:KEX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Top Fifteen Highest-Rated Dividend Companies

MarketBeat tracks approximately 175,000 ratings each year and tracks more than 15,000 securities around the globe that pay dividends each month or quarter.

This slide show lists the 15 dividend-paying companies (having yields above 25%) that also have the highest average analyst recommendations from Wall Street’s equities research analysts over the last 12 months.

View the “Top Fifteen Highest-Rated Dividend Companies”.

Related Posts:

  • No Related Posts

Shares in Adial Pharmaceuticals, Inc. (ADIL) -38.59 % down, YTD

The top two institutional holders are Vanguard Group, Inc. (The) with over 282.91 Thousand shares worth more than $367.78 Thousand. As of March …

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) has a beta value of 0 and has seen 1,007,894 shares traded in the last trading session. The company, currently valued at $19.91 Million, closed the last trade at $1.48 per share which meant it gained $0.02 on the day or 1.37% during that session. The ADIL stock price is -114.19% off its 52-week high price of $3.17 and 32.43% above the 52-week low of $1. If we look at the company’s 10-day average daily trading volume, we find that it stood at 335.22 Million shares traded. The 3-month trading volume is 494.91 Million shares.

The consensus among analysts is that Adial Pharmaceuticals, Inc. (ADIL) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.

Sporting 1.37% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jul 28 when the ADIL stock price touched $1.62 or saw a rise of 8.64%. Year-to-date, Adial Pharmaceuticals, Inc. shares have moved -38.59%, while the 5-day performance has seen it change 1.37%. Over the past 30 days, the shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) have changed 6.47%. Short interest in the company has seen 81.41 Million shares shorted with days to cover at 0.16.

Wall Street analysts have a consensus price target for the stock at $5, which means that the shares’ value could jump 237.84% from current levels. The projected low price target is $5 while the price target rests at a high of $5. In that case, then, we find that the current price level is +237.84% off the targeted high while a plunge would see the stock lose 237.84% from current levels.

Adial Pharmaceuticals, Inc. (ADIL) estimates and forecasts

Earnings growth for 2020 is a modest +64.3%.

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)’s Major holders

Insiders own 31.74% of the company shares, while shares held by institutions stand at 5.89% with a share float percentage of 8.63%. Investors are also buoyed by the number of investors in a company, with Adial Pharmaceuticals, Inc. having a total of 10 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 282.91 Thousand shares worth more than $367.78 Thousand. As of March 30, 2020, Vanguard Group, Inc. (The) held 2.1% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 205.68 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $267.39 Thousand and represent 1.53% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of March 30, 2020, the former fund manager holds about 1.31% shares in the company for having 176277 shares of worth $229.16 Thousand while later fund manager owns 106.63 Thousand shares of worth $138.62 Thousand as of March 30, 2020, which makes it owner of about 0.79% of company’s outstanding stock.

Related Posts:

  • No Related Posts

China Mobile Limited (NYSE: CHL) – Suitable For Long Term Buy?

And Renaissance Technologies LLC has lifted its position by 11.57% or 0.78 million shares – to 7.56 million shares. With over 0.73 million China …

Harding Loevner LP recently announced the acquisition of new stake in China Mobile Limited (NYSE:CHL). The institutional investor has increased its shareholding in the Communication Services company by 5.17% to 10.01 million shares with purchase of 0.49 million shares. This fresh investment now brings its stake to 0.24% valued currently at $336.8 million. In addition, Dimensional Fund Advisors LP raised its holdings by 1.5 million to 7.84 million shares. And Renaissance Technologies LLC has lifted its position by 11.57% or 0.78 million shares – to 7.56 million shares.

With over 0.73 million China Mobile Limited (CHL) shares trading Tuesday and a closing price of $34.07 on the day, the dollar volume was approximately $24.86 million. The shares have shown a negative weekly performance of -2.57% and its price on 07/28/20 lost nearly -0.47%. Currently, there are 4.10B common shares owned by the public and among those 1.12B shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 19 analysts who have offered their price forecasts for CHL have a consensus price objective of $45.50. The analysts have set the share’s price value over the next 12 months at a high of $58.06 and a low of $29.03 should the stock experience a downside. Incidentally, analysts’ outlook for the China Mobile Limited stock is 1.70 for the next 12 months. The average price target is 31.53% above its last price level and an upside to the estimated low will see the stock lose -17.36% over that period. But an upside of 41.32% will see the stock hit the forecast high price target while mean target price for the stock is $45.16.

The top 3 mutual fund holders in China Mobile Limited are Harding Loevner International Equ, DFA Emerging Markets Core Equity, and Lazard Emerging Markets Equity Po. Harding Loevner International Equ owns 5.08 million shares of the company’s stock, all valued at over $170.95 million. The company sold -0.29 million shares recently to bring their total holdings to about 0.12% of the shares outstanding. DFA Emerging Markets Core Equity bought 0.43 million shares to see its total holdings expand to 2.9 million shares valued at over $97.66 million and representing 0.07% of the shares outstanding. Lazard Emerging Markets Equity Po sold -0.5 million shares to bring its total holdings to over 2.65 million shares at a value of $89.19 million. Lazard Emerging Markets Equity Po now owns shares totaling to 0.07% of the shares outstanding.

Shares of China Mobile Limited (NYSE: CHL) opened at $34.14, down -$0.09 from a prior closing price of $34.23. However, the script later closed the day at $34.07, down -0.47%. The company’s stock has a 5-day price change of -2.57% and -15.42% over the past three months. CHL shares are trading -19.40% year to date (YTD), with the 12-month market performance down to -21.30% lower. It has a 12-month low price of $30.12 and touched a high of $44.93 over the same period. Currently, 0.73 million shares have been traded, compared to an average intraday trading volume of 1.34 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.73%, -3.15%, and -12.06% respectively.

Institutional ownership of China Mobile Limited (NYSE: CHL) shares accounts for 2.30% of the company’s 4.10B shares outstanding. Mutual fund holders own 0.65%, while other institutional holders and individual stakeholders account for 1.53% and — respectively.

It has a market capitalization of $138.64B and a beta (3y monthly) value of 0.52. The stock’s trailing 12-month PE ratio is 9.16, while the earnings-per-share (ttm) stands at $3.72. The company has a PEG of 1.87 and a Quick Ratio of 1.10 with the debt-to-equity ratio at 0.07. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.76% over the week and 1.12% over the month.

Analysts forecast that China Mobile Limited (CHL) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and $0 for 2008. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Earnings per share for the fiscal year are expected to decrease by -9.40%, and 8.68% over the next financial year. EPS should grow at an annualized rate of 4.90% over the next five years, compared to -0.50% over the past 5-year period.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 19 brokerage firm advisors rate China Mobile Limited (CHL) as a “Strong Buy” at a consensus score of 1.70. Specifically, 15 Wall Street analysts polled rate the stock as a buy, while 2 of the 19 advise that investors “hold,” and 1 rated it as a “Sell.”

Looking at the support for the CHL, a number of firms have released research notes about the stock. Daiwa Securities stated their Buy rating for the stock in a research note on October 01, 2019, with the firm’s price target at. Bernstein coverage for the China Mobile Limited (CHL) stock in a research note released on August 15, 2019 offered a Outperform rating with a price target of. Mizuho was of a view on August 08, 2019 that the stock is Neutral, while CLSA gave the stock Buy rating on August 08, 2019, issuing a price target of. Credit Suisse on their part issued Outperform rating on May 08, 2019.

Related Posts:

  • No Related Posts

4% jump drives Paramount Group, Inc. (PGRE) into becoming a top stock for investors

The top two institutional holders are Vanguard Group, Inc. (The) with over 28.46 Million shares worth more than $250.49 Million. As of March 30, 2020, …

Paramount Group, Inc. (NYSE:PGRE) has a beta value of 1.01 and has seen 2,427,920 shares traded in the last trading session. The company, currently valued at $1.61 Billion, closed the last trade at $7.28 per share which meant it gained $0.28 on the day or 4% during that session. The PGRE stock price is -106.04% off its 52-week high price of $15 and 11.81% above the 52-week low of $6.42. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.67 Million shares traded. The 3-month trading volume is 1.89 Million shares.

The consensus among analysts is that Paramount Group, Inc. (PGRE) is an Overweight stock at the moment, with a recommendation rating of 2.4. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 4 out of 8 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.01.

Sporting 4% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jul 28 when the PGRE stock price touched $7.32-0 or saw a rise of 0.55%. Year-to-date, Paramount Group, Inc. shares have moved -47.7%, while the 5-day performance has seen it change 2.97%. Over the past 30 days, the shares of Paramount Group, Inc. (NYSE:PGRE) have changed -4.46%. Short interest in the company has seen 3.67 Million shares shorted with days to cover at 1.94.

Wall Street analysts have a consensus price target for the stock at $11, which means that the shares’ value could jump 51.1% from current levels. The projected low price target is $8 while the price target rests at a high of $17. In that case, then, we find that the current price level is +133.52% off the targeted high while a plunge would see the stock lose 9.89% from current levels.

Paramount Group, Inc. (PGRE) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -19.4% over the past 5 years. Earnings growth for 2020 is a modest -521.8%.

PGRE Dividends

Paramount Group, Inc. is expected to release its next earnings report between July 29 and July 29 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.4 at a share yield of 5.71%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 2.64%.

Paramount Group, Inc. (NYSE:PGRE)’s Major holders

Insiders own 15.31% of the company shares, while shares held by institutions stand at 73.19% with a share float percentage of 86.42%. Investors are also buoyed by the number of investors in a company, with Paramount Group, Inc. having a total of 270 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 28.46 Million shares worth more than $250.49 Million. As of March 30, 2020, Vanguard Group, Inc. (The) held 12.84% of shares outstanding.

The other major institutional holder is Norges Bank Investment Management, with the holding of over 19.88 Million shares as of December 30, 2019. The firm’s total holdings are worth over $276.76 Million and represent 8.97% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Specialized-Real Estate Index Fund and Vanguard Total Stock Market Index Fund. As of April 29, 2020, the former fund manager holds about 3.75% shares in the company for having 8324601 shares of worth $80.33 Million while later fund manager owns 6.04 Million shares of worth $53.15 Million as of March 30, 2020, which makes it owner of about 2.72% of company’s outstanding stock.

Related Posts:

  • No Related Posts